PortfoliosLab logoPortfoliosLab logo
VYNE vs. NNN
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

VYNE vs. NNN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in VYNE Therapeutics Inc. (VYNE) and NNN REIT, Inc. (NNN). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, VYNE achieves a 13.41% return, which is significantly lower than NNN's 22.94% return.


VYNE

1D
3.18%
1M
1.45%
6M
17.48%
YTD
13.41%
1Y
-53.67%
3Y*
-46.18%
5Y*
-58.33%
10Y*

NNN

1D
1.26%
1M
1.65%
6M
18.08%
YTD
22.94%
1Y
16.22%
3Y*
9.10%
5Y*
5.18%
10Y*
4.27%
*Multi-year figures are annualized to reflect compound growth (CAGR)

VYNE vs. NNN - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
VYNE
VYNE Therapeutics Inc.
13.41%-82.68%43.78%-13.70%-85.29%-83.86%-65.95%12.62%-79.90%
NNN
NNN REIT, Inc.
22.94%2.81%-0.06%-0.60%-0.01%23.08%-19.29%14.78%24.27%

Correlation

The correlation between VYNE and NNN is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.12

Correlation (3Y)
Calculated over the trailing 3-year period

0.10

Correlation (5Y)
Calculated over the trailing 5-year period

0.12

Correlation (All Time)
Calculated using the full available price history since Jan 25, 2018

0.10

Fundamentals

Market Cap

VYNE:

$10.96M

NNN:

$9.01B

EPS

VYNE:

-$0.50

NNN:

$2.05

PS Ratio

VYNE:

61.96

NNN:

9.57

PB Ratio

VYNE:

1.14

NNN:

2.04

Total Revenue (TTM)

VYNE:

$454.00K

NNN:

$935.78M

Gross Profit (TTM)

VYNE:

$363.00K

NNN:

$761.54M

EBITDA (TTM)

VYNE:

-$23.76M

NNN:

$870.06M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

VYNE vs. NNN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VYNE
VYNE Risk / Return Rank: 2828
Overall Rank
VYNE Sharpe Ratio Rank: 2222
Sharpe Ratio Rank
VYNE Sortino Ratio Rank: 3535
Sortino Ratio Rank
VYNE Omega Ratio Rank: 3636
Omega Ratio Rank
VYNE Calmar Ratio Rank: 1919
Calmar Ratio Rank
VYNE Martin Ratio Rank: 2828
Martin Ratio Rank

NNN
NNN Risk / Return Rank: 7373
Overall Rank
NNN Sharpe Ratio Rank: 7575
Sharpe Ratio Rank
NNN Sortino Ratio Rank: 6969
Sortino Ratio Rank
NNN Omega Ratio Rank: 6666
Omega Ratio Rank
NNN Calmar Ratio Rank: 7777
Calmar Ratio Rank
NNN Martin Ratio Rank: 7676
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VYNE vs. NNN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for VYNE Therapeutics Inc. (VYNE) and NNN REIT, Inc. (NNN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


VYNENNNDifference
Sharpe ratioReturn per unit of total volatility

-1.46

Sortino ratioReturn per unit of downside risk

-1.35

Omega ratioGain probability vs. loss probability

1.01

1.17

-0.15

Calmar ratioReturn relative to maximum drawdown

-0.67

1.85

-2.51

Martin ratioReturn relative to average drawdown

-0.84

4.23

-5.06

VYNE vs. NNN - Sharpe Ratio Comparison

The current VYNE Sharpe Ratio is -0.51, which is lower than the NNN Sharpe Ratio of 0.95. The chart below compares the historical Sharpe Ratios of VYNE and NNN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

VYNE vs. NNN - Drawdown Comparison

The maximum VYNE drawdown since its inception was -99.99%, which is greater than NNN's maximum drawdown of -56.17%. Use the drawdown chart below to compare losses from any high point for VYNE and NNN.


Loading charts...

Drawdown Indicators


VYNENNNDifference

Max Drawdown

Largest peak-to-trough decline

-99.99%

-56.17%

-43.82%

Max Drawdown (1Y)

Largest decline over 1 year

-80.34%

-8.83%

-71.51%

Max Drawdown (3Y)

Largest decline over 3 years

-95.22%

-22.03%

-73.19%

Max Drawdown (5Y)

Largest decline over 5 years

-99.46%

-25.22%

-74.24%

Max Drawdown (10Y)

Largest decline over 10 years

-54.99%

Current Drawdown

Current decline from peak

-99.98%

-0.36%

-99.62%

Average Drawdown

Average peak-to-trough decline

-93.12%

-9.79%

-83.33%

Ulcer Index

Depth and duration of drawdowns from previous peaks

64.21%

3.85%

+60.36%

Volatility

VYNE vs. NNN - Volatility Comparison

VYNE Therapeutics Inc. (VYNE) has a higher volatility of 10.99% compared to NNN REIT, Inc. (NNN) at 5.83%. This indicates that VYNE's price experiences larger fluctuations and is considered to be riskier than NNN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


VYNENNNDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.99%

5.83%

+5.16%

Volatility (6M)

Calculated over the trailing 6-month period

20.16%

12.10%

+8.06%

Volatility (1Y)

Calculated over the trailing 1-year period

105.30%

17.17%

+88.13%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

105.06%

19.71%

+85.35%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

103.67%

28.11%

+75.56%

Dividends

VYNE vs. NNN - Dividend Comparison

VYNE has not paid dividends to shareholders, while NNN's dividend yield for the trailing twelve months is around 5.07%.


PositionTTM20252024202320222021202020192018201720162015
NNN
NNN REIT, Inc.
5.07%5.96%5.61%5.17%4.72%4.37%5.06%3.79%4.02%4.31%4.03%4.27%
VYNE
VYNE Therapeutics Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

VYNE vs. NNN - Financials Comparison

This section allows you to compare key financial metrics between VYNE Therapeutics Inc. and NNN REIT, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
86.00K
240.42M
(VYNE) Total Revenue
(NNN) Total Revenue
Values in USD except per share items

Frequently Asked Questions


VYNE and NNN have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

VYNE has higher volatility (10.99%) compared to NNN (5.83%). In terms of maximum drawdown, VYNE dropped -99.99% vs NNN's -56.17%.

NNN currently has the higher Sharpe Ratio (0.95 vs -0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for VYNE and NNN

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer